REGN

Biotechnology NTLA REGN Uncategorized

Intellia rises as FDA lifts clinical hold on Regeneron-partnered gene editing drug

Jan 27, 2026

Biotechnology CRVS REGN SNY Uncategorized

Corvus surges as lead asset advances to mid-stage trial in eczema

Jan 20, 2026

Biotechnology REGN Uncategorized

Regeneron upgraded at BoA on Eylea HD, Dupixent, and pipeline

Jan 7, 2026

alvotech,-teva-reach-settlement-with-regeneron-over-eylea-biosimilar-avt06-in-us.

ALVO Biotechnology REGN TEVA Uncategorized

Alvotech, Teva reach settlement with Regeneron over Eylea biosimilar AVT06 in U.S.

Dec 19, 2025

Luis Alvarez Alvotech (ALVO) and Teva Pharmaceuticals (TEVA) have reached a settlement and license agreement...

ABBV AMGN AZN Biotechnology BMY GILD GSK JNJ LLY MKGAF MRK NVO NVS PFE REGN SNY Uncategorized

More pharmas expected to sign drug pricing deals with Trump on Friday – report

Dec 17, 2025

biohaven-jumps-on-early-stage-data-for-antibody-drug-conjugate-combo

BHVN Biotechnology REGN Uncategorized

Biohaven jumps on early-stage data for antibody drug conjugate combo

Dec 11, 2025

On the Move Comments Love Employee Biohaven (BHVN) is up ~8% in Thursday trading after...

Biotechnology KYMR REGN SNY Uncategorized

Kymera jumps on early-stage data for eczema candidate KT-621

Dec 8, 2025

« Previous Page